Pharmacokinetics of glutathione and its metabolites in normal subjects
OConnor C, White KL, Doncescu N et al (2015) NMR structure and dynamics of the agonist dynorphin peptide bound to the human kappa opioid receptor
PLOS Medicine publishes research and commentary of general interest with clear implications for patient care, public policy or clinical research agendas
Notably, the nanoparticulate formulations of VCO, GSH, and their combined regimen demonstrated a substantial reduction in renal injury markers compared to their conventional drug-treated counterparts
It is however unfortunate that strict determinations of the effects of these genetic changes on TJ-structure and mucosal barrier function were not carried out in these studies
Change history 03 April 2019 A correction to this article has been published and is linked from the HTML and PDF versions of this paper